Current Report Filing (8-k)

Date : 10/29/2019 @ 8:38PM
Source : Edgar (US Regulatory)
Stock : Cigna Corporation (CI)
Quote : 217.19  -3.22 (-1.46%) @ 1:00AM
Cigna share price Chart
After Hours
Last Trade
Last $ 217.92 ▲ 0.73 (0.34%)

Current Report Filing (8-k)

0001739940 false false 0001739940 2019-10-23 2019-10-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) October 23, 2019

 

Cigna Corporation

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

001-38769

(Commission File Number)

82-4991898

(IRS Employer

Identification No.)

 

900 Cottage Grove Road

Bloomfield, Connecticut 06002

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code:

 

(860) 226-6000

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, Par Value $0.01 CI New York Stock Exchange, Inc.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On October 23, 2019, the board of directors (the “Board”) of Cigna Corporation (“Cigna”) appointed Kimberly A. Ross as an independent member of the Board, which appointment is effective June 1, 2020.

Ms. Ross will participate in Cigna’s non-employee director compensation program, amended and restated effective January 1, 2019, as described in Cigna’s proxy statement for the 2019 annual meeting of shareholders, filed with the Securities and Exchange Commission (the “SEC”) on March 15, 2019.  A copy of the non-employee director compensation program has been filed as Exhibit 10.18 to Cigna’s Annual Report on Form 10-K for the year ended December 31, 2018.

There is no arrangement or understanding between Ms. Ross and any other person pursuant to which Ms. Ross was selected as a director. Ms. Ross has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K promulgated under the Securities Exchange Act of 1934, as amended.

The Company will file an amended Form 8-K to disclose Ms. Ross’s committee assignments once determined.

A copy of Cigna's press release announcing the appointment of Ms. Ross is attached to this report as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Press release dated October 29, 2019
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

    Cigna Corporation
       
       
Date:  October 29, 2019   By:   /s/ Nicole S. Jones
      Nicole S. Jones
      Executive Vice President and
      General Counsel

 

 

 

Cigna (NYSE:CI)
Historical Stock Chart

1 Year : From Feb 2019 to Feb 2020

Click Here for more Cigna Charts.

Cigna (NYSE:CI)
Intraday Stock Chart

Today : Saturday 22 February 2020

Click Here for more Cigna Charts.

Latest CI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200222 20:12:39